Concepedia

Swamy Yeleswaram

SY

67

Publications

3.7K

Citations

33

H-Index

2005

Active since

Affiliations

Incyte (United States)(Current)

Experimental Station

Bristol-Myers Squibb (United States)

Swamy Yeleswaram is an author at Incyte (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2005–2024

67

Publications

67

Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050

Jordan S. Fridman, Peggy Scherle, Robert J. Collins et al. · The Journal of Immunology · 2010 · 440 citations · Full text

, , +21

The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers

Jack Shi, Xuejun Chen, Fiona Lee et al. · The Journal of Clinical Pharmacology · 2014 · 223 citations

, , +18

Discovery and Pharmacological Characterization of a Novel Rodent-Active CCR2 Antagonist, INCB3344

Carrie Brodmerkel, Reid Huber, Maryanne Covington et al. · The Journal of Immunology · 2005 · 187 citations

, , +13

Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis

Naresh Punwani, Peggy Scherle, Robert Flores et al. · Journal of the American Academy of Dermatology · 2012 · 181 citations

, , +5

The Pharmacokinetics, Pharmacodynamics, and Safety of Orally Dosed INCB018424 Phosphate in Healthy Volunteers

Jack Shi, Xuejun Chen, Ryan McGee et al. · The Journal of Clinical Pharmacology · 2011 · 164 citations

, , +8

Rows per page

1–5 of 67